A RCT of high-dose IFN induction followed by combination therapy with ribavirin in naive patients with chronic hepatitis C.

被引：0
|
作者：
Vaccaro, A [1 ]
Di Marco, V [1 ]
Ferraro, D [1 ]
Parisi, P [1 ]
Cappello, M [1 ]
Cino, N [1 ]
Di Stefano, R [1 ]
Almasio, PL [1 ]
Craxi, A [1 ]
机构：
[1] Univ Palermo, Palermo, Italy
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
815
引用
收藏
页码：363A / 363A
页数：1
相关论文
共 50 条
  • [31] Pilot study of interferon-alfa (IFNa) high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C
    Berg, T
    Hopf, U
    Naumann, U
    Schott, E
    Wiedenmann, B
    HEPATOLOGY, 1999, 30 (04) : 270A - 270A
  • [32] Hematological changes during IFN/ribavirin combination therapy in patients with chronic hepatitis C
    Wichlas, M
    Hofer, H
    Homoncik, M
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    Kreil, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 114 - 115
  • [33] Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
    Min, AD
    Jones, JL
    Esposito, S
    Lebovics, E
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Geders, JM
    Tobias, H
    Bodian, C
    Bodenheimer, HC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (04): : 1143 - 1149
  • [34] Induction treatment with combination therapy results in a lower relapse rate in naive patients with chronic hepatitis C.
    Rothstein, KD
    Pena, RE
    Suvannasankha, A
    DiGregorio, K
    Manzarbeitia, C
    Reich, DJ
    Bond, K
    Gross, F
    Shaw, E
    Peikin, S
    Mushnick, A
    Munoz, SJ
    HEPATOLOGY, 2000, 32 (04) : 560A - 560A
  • [35] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [36] Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy
    Steindl-Munda, P
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Gangl, A
    Vogel, W
    LIVER INTERNATIONAL, 2003, 23 (04) : 269 - 275
  • [37] A combined therapy with high dose of interferon (IFN)-alpha as an induction and ribavirin in non-responders to IFN alone with chronic hepatitis C
    Takashimizu, S
    Watanabe, N
    Mine, T
    Matsuzaki, S
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [38] A multi-center randomized trial comparing daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, NS
    Jeffries, MA
    Schutz, SM
    Sheinbaum, A
    Torivara, N
    Jolley, JJ
    Matossian, H
    Moulis, H
    Glombicki, AP
    Galen, E
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [39] Effect of initial interferon dosing and dose on response to combination therapy with ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Salzburg, LKH
    Steindl-Munda, P
    GASTROENTEROLOGY, 1999, 116 (04) : A1209 - A1209
  • [40] High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Gregor, M
    GASTROENTEROLOGY, 2000, 118 (04) : A951 - A951
12345